HFE, homeostatic iron regulator, 3077

N. diseases: 415; N. variants: 59
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 Biomarker disease CTD_human
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 Biomarker disease GENOMICS_ENGLAND
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 Biomarker disease GENOMICS_ENGLAND
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 GeneticVariation disease BEFREE Porphyria cutanea tarda associated with Cys282Tyr mutation in HFE gene in hereditary hemochromatosis: a case report and review of the literature. 18189029 2007
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 GeneticVariation disease BEFREE Porphyria cutanea tarda (PCT) is the most common human porphyria, due to hepatic deficiency of uroporphyrinogen decarboxylase (UROD), which is acquired in the presence of iron overload and various susceptibility factors, such as alcohol abuse, smoking, hepatitis C virus (HCV) infection, HIV infection, iron overload with HFE gene mutations, use of estrogens, and UROD mutation. 30683557 2019
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 GeneticVariation disease BEFREE Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda. 12622622 2003
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 GeneticVariation disease BEFREE Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients. 15101996 2004
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 Biomarker disease BEFREE HFE gene analysis should be done in patients who present with porphyria cutanea tarda. 15280838 2004
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 GeneticVariation disease BEFREE Hemochromatosis gene (HFE) mutations and the hepatitis C virus (HCV) are known risk factors for porphyria cutanea tarda (PCT), but interactions with erythrocytic uroporphyrinogen decarboxylase (UROD) have seldom been addressed. 19001803 2009
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 GeneticVariation disease BEFREE HFE mutations also appear to increase the likelihood of iron overload in inherited anemias and to promote the clinical manifestations of porphyria cutanea tarda. 9727731 1998
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 Biomarker disease LHGDN Association of porphyria cutanea tarda with hereditary hemochromatosis. 15280838 2004
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 GeneticVariation disease BEFREE Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda. 11069625 2000
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 Biomarker disease BEFREE Few studies have examined the connection between PCT and the regulation of iron metabolism genes other than the HFE gene. 29774528 2018
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 Biomarker disease LHGDN HFE gene in primary and secondary hepatic iron overload. 17729389 2007
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 GeneticVariation disease BEFREE Inherited factors that may predispose to PCT include the C282Y mutation in the hemochromatosis (HFE) gene. 11499833 2001
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 GeneticVariation disease BEFREE Inherited factors that, in combination, may predispose to PCT include mutations in the UROD gene, present in about 20% of patients, and the C282Y mutation in the haemochromatosis (HFE) gene. 9638727 1998
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 GeneticVariation disease BEFREE Investigation of porphyria cutanea tarda association with C282Y and H63D mutations in the HFE gene. 24068123 2014
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 GeneticVariation disease BEFREE Mutations of the UROD and hemochromatosis (HFE) genes are genetic factors in some PCT patients which can be mimicked in mice heterozygous for the Hfe and Urod null genes. 20099833 2010
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 GeneticVariation disease BEFREE Our data do not confirm an association of PCT with the Cys282Tyr HFE mutation, strongly associated with hemochromatosis in Northern European countries. 9425935 1998
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 GeneticVariation disease BEFREE Our results comprise the first molecular studies of both common and rare hemochromatosis gene variants in German PCT patients, indicating a significant role of the C282Y mutation in the pathogenesis of PCT. 17298224 2006
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 GeneticVariation disease LHGDN Our results comprise the first molecular studies of both common and rare hemochromatosis gene variants in German PCT patients, indicating a significant role of the C282Y mutation in the pathogenesis of PCT. 17298224 2006
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 GeneticVariation disease BEFREE Recent reports have described a significant association between inheritance of the C282Y and H63D mutations in the HFE gene, associated with genetic hemochromatosis (GH) and PCT. 12699243 2002
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 GeneticVariation disease BEFREE Results of recent studies have demonstrated high prevalences (about 60%-80%) of HFE gene mutations in patients with porphyria cutanea tarda. 12957298 2003
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 GeneticVariation disease BEFREE The HFE gene mutations were detected in 70% of patients with PCT compared with 35% in the control group (P < 0.001). 18565178 2008
CUI: C0162566
Disease: Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
0.600 GeneticVariation disease BEFREE The aims of this study were: 1) to assess the prevalence of HCV infection and HFE mutations in North American patients with PCT; 2) to compare demographic and laboratory features between those who are HCV-positive and HCV-negative; and 3) to study urinary porphyrin excretions in American HCV-positive patients without clinically manifest PCT. 9620340 1998